Literature DB >> 31336248

Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis.

Jingyin Bao1, Tianle Sun1, Yan Yue2, Sidong Xiong3.   

Abstract

Viral myocarditis, mainly caused by enteroviruses specially coxsackievirus B3 (CVB3) infection, is a common clinical cardiovascular disease and characterized by cardiac massive inflammation. Our previous study showed that CVB3-induced myocardial NLRP3 contributed to the development of viral myocarditis. In this study, we found that beside of being up-regulated in myocardiocytes, NLPR3 was also obviously increased in the cardiac infiltrating macrophages. While whether this accumulated NLRP3 influences, macrophage inflammatory responses remains unknown. By adoptive transfer assays, we found that mice receiving NLRP3 up-regulated macrophages showed much more abundant cardiac IL-1β production and more severe myocardial inflammation, while those receiving NLRP3 down-regulated macrophages showed much less IL-1β production and milder myocarditis, indicating that NLRP3 up-regulated macrophages played a pathological role in CVB3-induced myocarditis. In addition, we further found that it was CVB3 capsid proteins VP1 (predominant) and VP2, but not viral RNAs, robustly triggered macrophage NLRP3 up-regulation and activation. Our study demonstrated macrophage NLRP3 inflammasome could be efficiently be activated by CVB3 capsid proteins, and contributed to the pathogenesis of viral myocarditis. It might provide some clues to the development of new therapeutic strategies based on macrophage NLRP3 modulation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CVB3; Capsid protein; Macrophages; NLRP3; Viral myocarditis

Year:  2019        PMID: 31336248     DOI: 10.1016/j.molimm.2019.07.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.

Authors:  Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

2.  Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease.

Authors:  Le Yang; Lei Tian; Zhi Zhang; Xuan Zhou; Xiaofang Ji; Fuquan Liu; Chengbin Dong; Lei Hou; Xinhao Zhao; Na Chang; Lin Yang; Liying Li
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-28       Impact factor: 8.886

Review 3.  NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.

Authors:  Yucheng Wang; Xiaoxiao Liu; Hui Shi; Yong Yu; Ying Yu; Minghui Li; Ruizhen Chen
Journal:  Clin Transl Med       Date:  2020-04-09

4.  Long non-coding RNA MEG3 inhibits M2 macrophage polarization by activating TRAF6 via microRNA-223 down-regulation in viral myocarditis.

Authors:  Yu-Long Xue; Sheng-Xiao Zhang; Chao-Feng Zheng; Yu-Feng Li; Li-Hui Zhang; Qin-Yi Su; Yu-Fei Hao; Shu Wang; Xue-Wen Li
Journal:  J Cell Mol Med       Date:  2020-10-13       Impact factor: 5.310

5.  miR-1929-3p Overexpression Alleviates Murine Cytomegalovirus-Induced Hypertensive Myocardial Remodeling by Suppressing Ednra/NLRP3 Inflammasome Activation.

Authors:  YongJia Wang; Zhen Huang; Hua Zhong; LaMei Wang; DongMei Xi; YunZhong Shi; Wei Zhou; YongMin Liu; Na Tang; Fang He
Journal:  Biomed Res Int       Date:  2020-12-30       Impact factor: 3.411

Review 6.  Cerebral-Cardiac Syndrome and Diabetes: Cardiac Damage After Ischemic Stroke in Diabetic State.

Authors:  Hong-Bin Lin; Feng-Xian Li; Jin-Yu Zhang; Zhi-Jian You; Shi-Yuan Xu; Wen-Bin Liang; Hong-Fei Zhang
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  Luteolin Protects Cardiomyocytes Cells against Lipopolysaccharide-Induced Apoptosis and Inflammatory Damage by Modulating Nlrp3.

Authors:  Zhongfen Liu; Shaohua Gao; Ying Bu; Xiaoyan Zheng
Journal:  Yonsei Med J       Date:  2022-03       Impact factor: 2.759

8.  Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.

Authors:  Kathleen Pappritz; Jie Lin; Muhammad El-Shafeey; Henry Fechner; Uwe Kühl; Alessio Alogna; Frank Spillmann; Ahmed Elsanhoury; Rainer Schulz; Carsten Tschöpe; Sophie Van Linthout
Journal:  ESC Heart Fail       Date:  2022-02-17

9.  The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice.

Authors:  Jifei Chen; Fan Yang; Song Shi; Xuexiang Liu; Fengxian Qin; Xiaomou Wei; Yujie Huang; Wenwu Liang; Lin Miao
Journal:  Mediators Inflamm       Date:  2021-05-12       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.